Making it easier to take medicine
OUR WHY
Medicines don't work in people who don't take them. Oak Therapeutics increases treatment adherence by reformulating active pharmaceutical ingredients for novel delivery formats that will actually work for patients, especially in pediatrics, geriatrics, and other populations in need of solutions, including veterinary medicine. That's why we have received endorsements from organizations such as the Stop TB Partnership or the TB Alliance!
WHAT WE DO
Oak Therapeutics is the place to go when you have a drug delivery challenge. We have demonstrated success in developing proprietary Oral Thin Film / Oral Dissolvable Strip technology that allows for custom dosing, has the highest drug loading in the industry and allows for tailored dissolution times from seconds to multiple hours. We are the “never done before” and “impossible to do” formulation innovators, especially when it comes to antibiotics, antivirals, or pediatric populations.
ABOUT US
At Oak Therapeutics, we have a big vision. Our team is forging a new path “from bench to bedside” that offers patients pharmaceuticals and nutraceuticals that are acceptable, affordable and available to everyone. We are truly patient-centric, and our technology is protected by patents and trade secrets. With our innovative approach to drug delivery, we make good medicines great - as we have proven in multiple NIH-funded research projects!
Imagine a child with cancer that won't take prescribed medicines because they're too bitter. Picture a geriatric patient experiencing severe tremors. Think of a patient suffering from a neurological disease, or even your beloved pet. About one quarter of the general adult population, up to 75 % of stroke patients and people in nursing homes, 80 % of Parkinson’s patients and children with developmental disorders, and as much as 99 % of children suffering from cerebral palsy suffer from the inability to swallow tablets or capsules. Globally, every year 6 million children under five years of age die from diseases with relatively simple treatments such as tuberculosis or pneumonia because of the lack of regimen adherence, affordability, and accessibility.
At Oak Therapeutics, we address these challenges by making medicine easier to take so people take them as directed. We have demonstrated success in developing proprietary pharmaceutical formulations in a patient-friendly format for populations with solutions that work for them, primarily in the form of Oral Dissolvable Strips (ODS), sometimes also called Oral Thin Films (OTF). With the highest drug-loading in the industry for ODS (400mg) and the ability to target dissolution times from seconds to multiple hours, we are the “never done before” and “impossible to do” innovator for drug delivery challenges. Supported by grants and contracts from the National Institutes of Health (NIH) we have successfully reformulated actives such as isoniazid and rifapentine for the treatment of tuberculosis (TB) and latent tuberculosis (LTBI) or abacavir-lamivudine-dolutegravir (ALD) for the treatment of HIV/AIDS for delivery via ODS.
Market opportunities in this space are significant. The global market for Oral Thin Film / Oral Dissolvable Strips – one of our core capabilities – is expected to grow at a compound annual growth rate of 9.2% in the next 10 years. The market for geriatric and veterinary formulations will experience growth of approximately 7% annually, and the pediatric market will grow at approximately 5%.
At Oak Therapeutics, we make it easier to take medicine!
Interested in hearing more? Contact us!
2029 Becker
Lawrence, KS 66047
ph +1 (913) 346-0990
31416 Agoura Rd. Ste. 105
Westlake Village, CA 91361